Dendritic Cell Vaccination Combined with CTLA4 Blockade in Patients with Metastatic Melanoma

PURPOSE: Tumor antigen-loaded dendritic cells (DC) are believed to activate antitumor immunity by stimulating T cells, and cytotoxic T lymphocyte-associated antigen 4 (CTLA4)-blocking antibodies should release a key negative regulatory pathway on T cells. The combination was tested in a phase 1 clin...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Ribas, Antoni, Comin-Anduix, Begoña, Chmielowski, Bartosz, Jalil, Jason, de la Rocha, Pilar, McCannel, Tara A., Ochoa, Maria Teresa, Seja, Elizabeth, Villanueva, Arturo, Oseguera, Denise K., Straatsma, Bradley R., Cochran, Alistair J., Glaspy, John A., Hui, Liu, Marincola, Francesco M., Wang, Ena, Economou, James S., Gomez-Navarro, Jesus
Formato: Artigo
Idioma:Inglês
Publicado: 2009
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC2765061/
https://ncbi.nlm.nih.gov/pubmed/19789309
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-09-1254
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares